Hemocyte Plus

Manufacturer: U.S. Pharmaceutical Corporation
Effective date: 2023-06-13
Label type: DIETARY SUPPLEMENT
Version: 3
Source: full-release
Hydrated at: 2026-06-01 02:50:49

Label at a glance#

ProductHemocyte Plus

Active ingredientSODIUM ASCORBATE, THIAMINE MONONITRATE, RIBOFLAVIN, NIACIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, PANTOTHENIC ACID, FERROUS FUMARATE, MAGNESIUM SULFATE, UNSPECIFIED FORM, ZINC SULFATE, UNSPECIFIED FORM, CUPRIC SULFATE, MANGANESE SULFATE

Label structure7 sections

Label contents#

Full prescribing information#

STATEMENT OF IDENTITY SECTION

Supplement Facts Serving Size: 1 Capsule
Amount Per Serving		%DV*	%DVPLW**
Vitamin C (as Sodium Ascorbate)	187 mg	208%	156%
Vitamin B₁ (as Thiamine Hydrochloride)	10 mg	833%	714%
Vitamin B₂ (Riboflavin)	6 mg	462%	375%
Vitamin B₃ (as Niacinamide)	30 mg	188%	167%
Vitamin B₆ (Pyridoxine HCl)	5 mg	294%	250%
Folic Acid	1 mg	250%	167%
Vitamin B₁₂ (Cyanocobalamin)	15 mcg	625%	536%
Pantothenic Acid (as D-Calcium Pantothenate)	10 mg	200%	143%
Iron (from Ferrous Fumarate)	106 mg	589%	393%
Magnesium (as Magnesium Sulfate)	6.9 mg	2%	2%
Zinc (as Zinc Sulfate)	18 mg	164%	138%
Copper (as Copper Sulfate)	0.8 mg	89%	62%
Manganese (as Manganese Sulfate)	1.3 mg	57%	50%
% Daily Values are based on a 2,000 calorie intake of adults and children 12 years and older. *% Daily Value for Pregnant or Lactating Women

Other Ingredients: Dibasic Calcium Phosphate, Gelatin, Magnesium Stearate, Silicon Dioxide, Titanium Dioxide, FD&C RED #40 and FD&C Blue #2

INDICATIONS: For the treatment of iron deficiency anemia and folate deficiency as normally found in chronic extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. Also for correction of conditions in which iron deficiency and vitamin C deficiency occur together, along with a deficient intake or increased need for B-Complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence.

CONTRAINDICATIONS: HEMOCYTE PLUS® CAPSULES are contraindicated in patients with a known hypersensitivity to any of its ingredients. Also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, and hemolytic anemias. Pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

In case of accidental overdose call a doctor or poison control center immediately. Iron is toxic. When overdoses are ingested by children, severe reactions, including fatalities, have resulted. HEMOCYTE PLUS® CAPSULES should be stored beyond the reach of children to protect against accidental iron poisoning. Keep this and all drugs out of the reach of children.

WARNINGS SECTION

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

WARNING: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B₁₂ is deficient.

You should contact your healthcare provider for medical advice about adverse events. To report a serious adverse event, contact US Pharmaceutical Corporation, P.O. Box 360465, Decatur, GA 30036

PRECAUTIONS SECTION

PRECAUTIONS: General: Folic acid in doses above 0.1 mg - 0.4 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.

PEDIATRIC USE: Safety and effectiveness in pediatric patients have not been established.

ADVERSE REACTION:
Allergic reactions have been reported following both oral and parenteral administration of folic acid. Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and subside with continuation of therapy and physician encouragement. Although the absorption of iron is best when taken between meals, occasional G.I. disturbances may be controlled by giving HEMOCYTE PLUS® CAPSULES shortly after meals.

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND ADMINISTRATION: Adults only: 1 capsule daily, between meals, orally. Do not exceed recommended dosage. Do not administer to children.

HOW SUPPLIED: HEMOCYTE PLUS® CAPSULES are maroon capsules printed in black with "US" logo on both cap and body. Available in boxes of 30 blisterpacked capsules (52747-0800-30) and 100 blisterpacked capsules (52747-0800-60). The listed product numbers are not National Drug Codes. Instead, US Pharmaceutical Corporation has assigned these product codes formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.

SAFE HANDLING WARNING SECTION

Store at room temperature 15° to 30°C (59° to 86°F) and dry place.

CAUTION: Rx only.

Rev. 11/2022

uspco.com

HEALTH CLAIM SECTION

Iron-Vitamin-Mineral Complex Supplement

RESERVED FOR PROFESSIONAL RECOMMENDATION. Made in the USA exclusively for US Pharmaceutical Corporation, P.O. Box 360465, Decatur, GA 30036. All rights reserved. The appearance and the name of Hemocyte Plus® CAPS or Hemocyte Plus® CAPSULES are trademarks of US Pharmaceutical Corporation. The appearance of the Iron / Vitamin / Mineral combination is a trademark of US Pharmaceutical Corporation. The use of the product information pamphlet is expressly prohibited without prior written consent.

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

HemocytePlus80060

RxCUI, Display, Full name table
RxCUI	Display	Full name	Type	Form / route
1087399	HEMOCYTE PLUS (Oral Pill)	copper sulfate 0.8 MG / ferrous fumarate 324 MG / folic acid 1 MG / magnesium sulfate 6.9 MG / manganese sulfate 1.3 MG / niacinamide 30 MG / pantothenic acid 10 MG / pyridoxine 5 MG / riboflavin 6 MG / sodium ascorbate 200 MG / thiamine 10 MG / vitamin B12 0.015 MG / zinc sulfate 18.2 MG Oral Capsule [Hemocyte Plus]	SBD Active

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
ASCORBIC ACID Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813
CYANOCOBALAMIN Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813
MAGNESIUM CATION Pharmacologic Class Indexing	4	Indexing - Pharmacologic Class	20180813
MANGANESE CATION (2+) Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813
NIACIN Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813
PYRIDOXINE Pharmacologic Class Indexing	1	Indexing - Pharmacologic Class	20170310
ZINC CATION Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
6e3c022f-0786-43f1-8857-edff89d5153f	Product name	1	20260309
f47a510b-6679-4664-b2d6-47b5c4afe7cc	Product name	4	20260217
95250459-30e4-45c1-b08a-993044f49109	Product name	2	20250805
cf050ccd-1144-f76a-e00d-e5698d8597d4	Product name	6	20250625
030ce964-9b2d-45aa-b5d3-f78ce03ef61c	Product name	2	20250515
59361619-24d9-b610-eca6-5a7f25ed5e03	Product name	5	20240909
b82b4008-22fd-05f5-6cc6-c0a6e81c65b8	Product name	2	20240805
efd58652-cb8f-4018-91ca-4b0eb2ff729f	Product name	7	20240226
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
0306390c-dd77-4363-afe0-63c58088b2a1	Product name	1	20220120
503ea967-4b9c-48cf-9e87-c7975295849d	Product name	2	20220120
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
2641ccb3-721d-4fbf-9f2f-ca2f18157a62	Product name	3	20210309
91c62db0-0295-c81c-d10a-0856c259edd6	Product name	2	20200428
d32bc2b8-0bb7-2216-87aa-24639646e202	Product name	3	20190619
e2dae634-14ed-febf-08ee-93196433b5b7	Product name	9	20190614
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125
c5cd4727-ac49-4409-82b1-5bd8006c3ec7	Product name	1	20171122
d206bb34-ea65-399d-70d9-834f22dc2c18	Product name	3	20170724
26acd337-b838-40ac-bcbc-05c3b81c8712	Product name	1	20170323
5e18e798-5614-cf5c-0185-38b1cb77a093	Product name	2	20160822
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
e7e58cd3-cacb-49df-8d34-1ee335614abb	Product name	1	20150609
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
0a5e5249-329b-0cff-e714-77159f193a87	Product name	1	20140508
190f2a5b-bbc8-65c7-fcb0-97891307b917	Product name	1	20140508
6b7a6f32-42a6-994d-5ab6-d180e92ee9d8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
d394f843-7479-dc48-dbd3-232266c5548c	Product name	1	20140508
dc9a5fb6-14e2-1cc8-a567-a781fd1f0212	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
52747-800-60	Hemocyte Plus	10 in 1 BOX	CAPSULE	10		3
52747-800-60	Hemocyte Plus	10 in 1 BLISTER PACK	CAPSULE	10		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52747-800	HEMOCYTE PLUS (IRON-VITAMIN-MINERAL COMPLEX SUPPLEMENT) CAPSULE [U.S. PHARMACEUTICAL CORPORATION]	3	2 package rows	20230623_3be7dd24-8a5c-455a-b67c-d1511ce3b535.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
52747-800-30	EA - Each	52747-800	8f3b87e4-346c-4c74-8ab5-8dc38b84c767	1	2014-11-05
52747-800-60	EA - Each	52747-800	baec4eb7-6b7e-4b57-93ff-b859c4529671	1	2014-11-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CUPRIC SULFATE	ACTIVE INGREDIENT	LRX7AJ16DT	1
CYANOCOBALAMIN	ACTIVE INGREDIENT	P6YC3EG204	1
FERROUS FUMARATE	ACTIVE INGREDIENT	R5L488RY0Q	1
FOLIC ACID	ACTIVE INGREDIENT	935E97BOY8	1
MAGNESIUM SULFATE	ACTIVE INGREDIENT	DE08037SAB	1
MANGANESE SULFATE	ACTIVE INGREDIENT	W00LYS4T26	1
NIACIN	ACTIVE INGREDIENT	2679MF687A	1
PANTOTHENIC ACID	ACTIVE INGREDIENT	19F5HK2737	1
PYRIDOXINE HYDROCHLORIDE	ACTIVE INGREDIENT	68Y4CF58BV	1
RIBOFLAVIN	ACTIVE INGREDIENT	TLM2976OFR	1
SODIUM ASCORBATE	ACTIVE INGREDIENT	S033EH8359	1
THIAMINE MONONITRATE	ACTIVE INGREDIENT	8K0I04919X	1
ZINC SULFATE	ACTIVE INGREDIENT	89DS0H96TB	1
ASCORBIC ACID	ACTIVE MOIETY	PQ6CK8PD0R	1
CUPRIC CATION	ACTIVE MOIETY	8CBV67279L	1
CYANOCOBALAMIN	ACTIVE MOIETY	P6YC3EG204	1
FERROUS CATION	ACTIVE MOIETY	GW89581OWR	1
FOLIC ACID	ACTIVE MOIETY	935E97BOY8	1
MAGNESIUM CATION	ACTIVE MOIETY	T6V3LHY838	1
MANGANESE CATION (2+)	ACTIVE MOIETY	H6EP7W5457	1
NIACIN	ACTIVE MOIETY	2679MF687A	1
PANTOTHENIC ACID	ACTIVE MOIETY	19F5HK2737	1
PYRIDOXINE	ACTIVE MOIETY	KV2JZ1BI6Z	1
RIBOFLAVIN	ACTIVE MOIETY	TLM2976OFR	1
THIAMINE ION	ACTIVE MOIETY	4ABT0J945J	1
ZINC CATION	ACTIVE MOIETY	13S1S8SF37	1
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 30 matching rows.

Hemocyte Plus
Iron-Vitamin-Mineral Complex Supplement
SODIUM ASCORBATE
ASCORBIC ACID
THIAMINE MONONITRATE
THIAMINE ION
RIBOFLAVIN
NIACIN
PYRIDOXINE HYDROCHLORIDE
PYRIDOXINE
FOLIC ACID
CYANOCOBALAMIN
PANTOTHENIC ACID
FERROUS FUMARATE
FERROUS CATION
MAGNESIUM SULFATE, UNSPECIFIED FORM
MAGNESIUM CATION
ZINC SULFATE, UNSPECIFIED FORM
ZINC CATION
CUPRIC SULFATE
CUPRIC CATION
MANGANESE SULFATE
MANGANOUS CATION
GELATIN, UNSPECIFIED
MAGNESIUM STEARATE
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
SILICON DIOXIDE
TITANIUM DIOXIDE
FD&C RED NO. 40
FD&C BLUE NO. 2

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
52747-800	52747-800-60

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SODIUM ASCORBATE	S033EH8359	ACTIM
THIAMINE MONONITRATE	8K0I04919X	ACTIR
RIBOFLAVIN	TLM2976OFR	ACTIB
NIACIN	2679MF687A	ACTIB
PYRIDOXINE HYDROCHLORIDE	68Y4CF58BV	ACTIM
FOLIC ACID	935E97BOY8	ACTIB
CYANOCOBALAMIN	P6YC3EG204	ACTIB
PANTOTHENIC ACID	19F5HK2737	ACTIB
FERROUS FUMARATE	R5L488RY0Q	ACTIM
MAGNESIUM SULFATE, UNSPECIFIED FORM	DE08037SAB	ACTIB
ZINC SULFATE, UNSPECIFIED FORM	89DS0H96TB	ACTIM
CUPRIC SULFATE	LRX7AJ16DT	ACTIM
MANGANESE SULFATE	W00LYS4T26	ACTIM
GELATIN, UNSPECIFIED	2G86QN327L	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	L11K75P92J	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
FD&C RED NO. 40	WZB9127XOA	IACT
FD&C BLUE NO. 2	L06K8R7DQK	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 226 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / BUCCAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL		980 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	SOAP / TOPICAL	1 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	PASTILLE / ORAL	143 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	INJECTION / INTRAMUSCULAR	16 %w/v		Exact identifier — unii candidate 44 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED / ORAL		166 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	DROPS / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		9 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	ANHYDROUS DIBASIC CALCIUM PHOSPHATE	L11K75P92J	TABLET, COATED / ORAL	333.3 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / ORAL		750 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, EXTENDED RELEASE / ORAL		450 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	TABLET, FILM COATED / ORAL	2.5 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		336 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	14 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / NASAL		20 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FOR SUSPENSION / ORAL		220 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	ELIXIR / ORAL	12.5 mg/5ml		Exact identifier — unii candidate 28 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	SOLUTION / INTRAVENOUS	34.8 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, LIQUID FILLED / ORAL		12 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / ORAL		602 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	CAPSULE / ORAL		16 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL		232 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	DROPS / ORAL	NA		Exact identifier — unii candidate 40 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, DELAYED RELEASE / ORAL		1060 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, DELAYED RELEASE / ORAL		144 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	CAPSULE, EXTENDED RELEASE / ORAL		1 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER, FOR SUSPENSION / ORAL		120 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	TABLET / PERIODONTAL	3.44 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	GRANULE, FOR SUSPENSION / ORAL		143 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
FD&C BLUE NO. 2	FD&C BLUE NO. 2	L06K8R7DQK	TABLET, CHEWABLE / ORAL		3 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL		68 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	SUSPENSION / ORAL	100 mg/5ml		Exact identifier — unii candidate 28 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	DROPS / ORAL	NA		Exact identifier — unii candidate 28 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, COATED / ORAL		17 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	OINTMENT / TOPICAL	5 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	PASTE, DENTIFRICE / DENTAL	0.4 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	POWDER / RESPIRATORY (INHALATION)	2 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	LOZENGE / ORAL		120 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE / ORAL		254 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FD&C BLUE NO. 2	FD&C BLUE NO. 2	L06K8R7DQK	TABLET, FILM COATED / ORAL		2 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		1 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	CAPSULE, DELAYED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	CAPSULE, COATED / ORAL	NA		Exact identifier — unii candidate 28 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	SYSTEM / TOPICAL		420 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	TABLET / ORAL		46 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	CAPSULE / ORAL		10932 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CREAM / TOPICAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / TOPICAL		104 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	14 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	POWDER, FOR SUSPENSION / ORAL		3 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	ANHYDROUS DIBASIC CALCIUM PHOSPHATE	L11K75P92J	TABLET, CHEWABLE / ORAL	50 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
FD&C BLUE NO. 2	FD&C BLUE NO. 2	L06K8R7DQK	CAPSULE, EXTENDED RELEASE / ORAL		4 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	FILM, EXTENDED RELEASE / TRANSDERMAL	NA		Exact identifier — unii candidate 40 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	INSERT / VAGINAL		8 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	GUM, CHEWING / BUCCAL		48 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / RESPIRATORY (INHALATION)	0.13 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / VAGINAL	8 %w/w		Exact identifier — unii candidate 49 equally ranked IID candidates

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.